A single-chain bispecific Fv2 molecule produced in mammalian cells redirects lysis by activated CTL
- 1 February 1996
- journal article
- research article
- Published by Elsevier in Molecular Immunology
- Vol. 33 (2) , 211-219
- https://doi.org/10.1016/0161-5890(95)00087-9
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Stabilization of the Fv fragments in recombinant immunotoxins by disulfide bonds engineered into conserved framework regionsBiochemistry, 1994
- Engineering bispecific antibodiesCurrent Opinion in Biotechnology, 1993
- Localization of monoclonal antibody G250 and bispecific monoclonal antibody CD3/G250 in human renal‐cell carcinoma xenografts: Relative effects of size and affinityInternational Journal of Cancer, 1991
- Targeting and Activation of Cytotoxic Lymphocytes (Part 1 of 2)Published by S. Karger AG ,1989
- Specific targeting of human peripheral blood T cells by heteroaggregates containing anti-T3 crosslinked to anti-target cell antibodies.The Journal of Experimental Medicine, 1986
- Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibodyNature, 1985
- Hybrid antibodies can target sites for attack by T cellsNature, 1985
- Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factorThe Journal of Experimental Medicine, 1981
- Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors.The Journal of Experimental Medicine, 1979
- Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysisCell, 1978